Research & Development



  我們用命闖出來的名聲,地位,財富,只要官府一聲令下,我們就會全部失去。   霍光冷哼一聲,護衛劉據的甲士就慌忙將劉據捉回來,重新用巨盾護的嚴嚴實實。24日福利彩票出奖号码   原本已經搬去跟甦煥一起居住的甦子良夫婦听說甦稚懷孕之後自然就回到了雲氏。2014河北竞彩彩票站   即便是雲瑯守在犬台宮外邊,也能听到里面傳來激烈的狗吠之聲。   這就是張安世這段時間做的主要工作,很明顯,他的工作是卓有成效的。2014体育彩票放假   因此,雲瑯不能容忍江充這種人在世上多活一刻。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo